Products Categories
| CAS No.: | 5443-49-2 |
|---|---|
| Name: | 2-Bromocinnamaldehyde |
| Molecular Structure: | |
|
|
|
| Formula: | C9H7BrO |
| Molecular Weight: | 211.058 |
| Synonyms: | Cinnamaldehyde,a-bromo- (6CI,7CI,8CI);2-Bromo-3-phenylacrolein;Alphabrocine;B 36;B 37;NSC19806;a-Bromocinnamic aldehyde;Alpha-bromocinnamaldehyde; |
| EINECS: | 226-637-6 |
| Density: | 1.499 g/cm3 |
| Melting Point: | 66-68 °C(lit.) |
| Boiling Point: | 304.4 °C at 760 mmHg |
| Flash Point: | 110.2 °C |
| Appearance: | light yellow to ochre crystalline powder |
| Hazard Symbols: |
Xn
|
| Risk Codes: | 22-36/37/38 |
| Safety: | 26-36/37/39-22 |
| PSA: | 17.07000 |
| LogP: | 2.62130 |
What can I do for you?
Get Best Price
Molecular structure of 2-Bromocinnamaldehyde (CAS NO.5443-49-2) is:

Product Name: 2-Bromocinnamaldehyde
CAS Registry Number: 5443-49-2
IUPAC Name: (Z)-2-bromo-3-phenylprop-2-enal
Molecular Weight: 211.05528 [g/mol]
Molecular Formula: C9H7BrO
XLogP3-AA: 2.7
H-Bond Donor: 0
H-Bond Acceptor: 1
EINECS: 226-637-6
Melting Point: 66-68 °C(lit.)
Surface Tension: 46.4 dyne/cm
Density: 1.499 g/cm3
Flash Point: 110.2 °C
Enthalpy of Vaporization: 54.48 kJ/mol
Boiling Point: 304.4 °C at 760 mmHg
Vapour Pressure: 0.000874 mmHg at 25°C
Product Categories: Pharmaceutical Intermediates;Aromatic Cinnamic Acids, Esters and Derivatives;Aldehydes;C9;Carbonyl Compounds
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 822mg/kg (822mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 919, 1969. |
| mouse | LD50 | oral | 470mg/kg (470mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ATAXIA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. Vol. 36(1-4), Pg. 10, 1989. |
| mouse | LD50 | subcutaneous | 2200mg/kg (2200mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 919, 1969. |
| rat | LD50 | intraperitoneal | 513mg/kg (513mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 919, 1969. |
| rat | LD50 | oral | 1450mg/kg (1450mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 919, 1969. |
| rat | LD50 | subcutaneous | 1210mg/kg (1210mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 919, 1969. |
Safty information about 2-Bromocinnamaldehyde (CAS NO.5443-49-2) is:
Hazard Codes:
Xn
Risk Statements: 22-36/37/38
R22:Harmful if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37/39-22
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S22:Do not breathe dust.
WGK Germany: 3
RTECS: GD6480000
2-Bromocinnamaldehyde , its cas register number is 5443-49-2. It also can be called 2-Propenal,2-bromo-3-phenyl- ; Bromocinnamal ; alpha-Bromocinnamaldehyde ; 2-Bromo-3-phenyl-2-propenal ; 2-Bromocinnamaldehyde ; 2-Propenal, 2-bromo-3-phenyl- (9CI) ; Cinnamaldehyde, alpha-bromo- .It is a light yellow to ochre crystalline powder.